These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 23397110)
1. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers. Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110 [TBL] [Abstract][Full Text] [Related]
2. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma. Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382 [TBL] [Abstract][Full Text] [Related]
3. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging. Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730 [TBL] [Abstract][Full Text] [Related]
4. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma. Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863 [TBL] [Abstract][Full Text] [Related]
5. Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach. Zhang Y; Wang J; Dai N; Han P; Li J; Zhao J; Yuan W; Zhou J; Zhou F BMC Cancer; 2020 Sep; 20(1):835. PubMed ID: 32878621 [TBL] [Abstract][Full Text] [Related]
6. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform. Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477 [TBL] [Abstract][Full Text] [Related]
7. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. Cui Y; Xue Y; Dong S; Zhang P J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538 [TBL] [Abstract][Full Text] [Related]
8. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma. Cheng J; Zheng G; Jin H; Gao X Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565 [TBL] [Abstract][Full Text] [Related]
9. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466 [TBL] [Abstract][Full Text] [Related]
10. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma. Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700 [TBL] [Abstract][Full Text] [Related]
11. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma. Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715 [TBL] [Abstract][Full Text] [Related]
12. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy. Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622 [TBL] [Abstract][Full Text] [Related]
13. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. Wang WT; Guo CQ; Cui GH; Zhao S World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161 [TBL] [Abstract][Full Text] [Related]
14. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476 [TBL] [Abstract][Full Text] [Related]
15. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma. Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of plasma miRNA-718 for esophageal squamous cell carcinoma. Sun L; Dong S; Dong C; Sun K; Meng W; Lv P; Yin H; Ming L; He F Cancer Biomark; 2016; 16(2):265-73. PubMed ID: 26756617 [TBL] [Abstract][Full Text] [Related]
17. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176 [TBL] [Abstract][Full Text] [Related]
18. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study. Fan NJ; Gao CF; Wang XL OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306 [TBL] [Abstract][Full Text] [Related]
19. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. Chang WL; Lai WW; Kuo IY; Lin CY; Lu PJ; Sheu BS; Wang YC J Gastroenterol; 2017 Jun; 52(6):705-714. PubMed ID: 27671002 [TBL] [Abstract][Full Text] [Related]
20. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma. Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]